Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study

This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subj...

Full description

Saved in:
Bibliographic Details
Published inJournal of bone and mineral metabolism Vol. 37; no. 6; pp. 1058 - 1066
Main Authors Yoshimura, Noriko, Muraki, Shigeyuki, Iidaka, Toshiko, Oka, Hiroyuki, Horii, Chiaki, Kawaguchi, Hiroshi, Akune, Toru, Nakamura, Kozo, Tanaka, Sakae
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.11.2019
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried’s definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability.
AbstractList This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried’s definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability.
This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried’s definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability.
This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried's definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability.This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried's definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability.
Author Muraki, Shigeyuki
Yoshimura, Noriko
Iidaka, Toshiko
Oka, Hiroyuki
Akune, Toru
Nakamura, Kozo
Tanaka, Sakae
Horii, Chiaki
Kawaguchi, Hiroshi
Author_xml – sequence: 1
  givenname: Noriko
  orcidid: 0000-0002-6555-5782
  surname: Yoshimura
  fullname: Yoshimura, Noriko
  email: yoshimuran-ort@h.u-tokyo.ac.jp
  organization: Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo
– sequence: 2
  givenname: Shigeyuki
  surname: Muraki
  fullname: Muraki, Shigeyuki
  organization: Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo
– sequence: 3
  givenname: Toshiko
  surname: Iidaka
  fullname: Iidaka, Toshiko
  organization: Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo
– sequence: 4
  givenname: Hiroyuki
  surname: Oka
  fullname: Oka, Hiroyuki
  organization: Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical and Research Center, Faculty of Medicine, University of Tokyo
– sequence: 5
  givenname: Chiaki
  surname: Horii
  fullname: Horii, Chiaki
  organization: Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo
– sequence: 6
  givenname: Hiroshi
  surname: Kawaguchi
  fullname: Kawaguchi, Hiroshi
  organization: Tokyo Neurological Center
– sequence: 7
  givenname: Toru
  surname: Akune
  fullname: Akune, Toru
  organization: National Rehabiliation Center for Persons with Disabilities
– sequence: 8
  givenname: Kozo
  surname: Nakamura
  fullname: Nakamura, Kozo
  organization: Towa Hospital
– sequence: 9
  givenname: Sakae
  surname: Tanaka
  fullname: Tanaka, Sakae
  organization: Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31222550$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAUhUVJaSZpX6CLIugmhbjRny27uyFJfyAwJbRrI0vXGQWPNJXkoX6jPmbkmbSFLLK4EhLfOfdyzwk6ct4BQm8p-UgJkRcxH1IUhDa5CGUFeYEWVPCyKCsijtCCNFQUtZTNMTqJ8Z4QKktJX6FjThljZUkW6M_3ADs1gNOAlTNY-wJ-25j2H77Hg9d-45PdAY6TM8Fv4BxHFbTfgrPqfC_qg7JDmj7htIZcNhgcx7CDaXa4hQiZX2Pv8CobexXSOthk48X-ufXBRxvx8k5ZFxO-slF1drBpwme3q-XVBxzTaKbX6GWvhghvHu9T9PPz9Y_Lr8XN6su3y-VNoUVVpqLrNYe6FFXdV40B1pWai64SveGCgaJSyKauoGZGd52UhtNSqF4DN7VgHev5KTo7-G6D_zVCTO3GRg3DoBz4MbaMibxdVosqo--foPd-DC5PN1O8zkwjMvXukRq7DZh2G-xGhan9m0EG2AHQeRExQP8PoaSdg24PQbc56HYfdDuL6icibZNK1rs0h_G8lB-kMfdxdxD-j_2M6gFN9b7_
CitedBy_id crossref_primary_10_1177_23094990211060967
crossref_primary_10_2490_jjrmc_56_888
crossref_primary_10_1007_s10067_023_06639_z
crossref_primary_10_1186_s41100_021_00352_w
crossref_primary_10_1371_journal_pone_0269103
crossref_primary_10_1589_jpts_34_440
crossref_primary_10_1186_s12891_022_05738_3
crossref_primary_10_1016_j_jbmt_2023_04_031
crossref_primary_10_3389_fpsyt_2024_1464285
crossref_primary_10_34142_HSR_2023_09_01_05
crossref_primary_10_1186_s12891_020_03469_x
crossref_primary_10_1186_s12891_023_06686_2
crossref_primary_10_1186_s12877_021_02440_2
crossref_primary_10_1111_ggi_15026
crossref_primary_10_1093_mr_roac101
crossref_primary_10_1016_j_ajoms_2020_04_005
crossref_primary_10_1016_j_jos_2022_11_021
crossref_primary_10_2490_jjrmc_58_605
crossref_primary_10_1111_ggi_14779
crossref_primary_10_2490_prm_20220014
crossref_primary_10_1007_s10147_023_02312_2
crossref_primary_10_3390_nu13051730
crossref_primary_10_3390_jcm12134345
crossref_primary_10_1186_s12891_020_03547_0
crossref_primary_10_12965_jer_2244234_117
crossref_primary_10_1016_j_bone_2022_116570
crossref_primary_10_1007_s43657_023_00122_0
crossref_primary_10_2139_ssrn_4191850
crossref_primary_10_31612_2616_4868_4_26__2023_01
crossref_primary_10_1002_ejp_2156
crossref_primary_10_1016_j_jos_2024_07_003
crossref_primary_10_1186_s12877_023_03828_y
crossref_primary_10_3390_jcm12175626
crossref_primary_10_1589_jpts_33_362
crossref_primary_10_1111_ggi_14785
crossref_primary_10_1093_mr_roab024
crossref_primary_10_1080_14397595_2021_1899890
crossref_primary_10_1093_mr_roac039
crossref_primary_10_1371_journal_pone_0245879
crossref_primary_10_1111_jdi_13291
crossref_primary_10_37586_2686_8636_3_2021_364_370
crossref_primary_10_1016_j_jos_2020_06_012
crossref_primary_10_1111_ggi_14627
crossref_primary_10_1136_bmjopen_2022_068645
crossref_primary_10_1016_j_jocn_2023_08_012
crossref_primary_10_7759_cureus_64612
crossref_primary_10_1016_j_jos_2020_02_006
crossref_primary_10_1016_j_jos_2025_01_004
crossref_primary_10_1111_ggi_14273
crossref_primary_10_3390_jcm9041216
crossref_primary_10_1589_rika_36_623
crossref_primary_10_1038_s41598_023_46558_2
crossref_primary_10_1111_ggi_14593
crossref_primary_10_22603_ssrr_2021_0088
crossref_primary_10_1016_j_bbrc_2021_10_043
crossref_primary_10_1186_s40101_023_00334_3
crossref_primary_10_7717_peerj_9026
crossref_primary_10_1186_s12877_023_04405_z
crossref_primary_10_1016_j_maturitas_2020_11_009
crossref_primary_10_1016_j_jos_2021_02_003
crossref_primary_10_2490_prm_20200029
crossref_primary_10_1093_heapro_daae164
crossref_primary_10_1093_mr_roac004
crossref_primary_10_1080_07399332_2022_2083620
crossref_primary_10_1002_jcsm_12870
crossref_primary_10_1186_s12891_021_04421_3
crossref_primary_10_3390_geriatrics7030069
crossref_primary_10_1590_1980_265x_tce_2020_0494
crossref_primary_10_36425_rehab630518
crossref_primary_10_1002_acr_24342
crossref_primary_10_3390_ijerph17197272
crossref_primary_10_1016_j_jos_2022_03_004
crossref_primary_10_1111_ggi_14162
crossref_primary_10_7717_peerj_12292
crossref_primary_10_1002_14651858_CD013088_pub2
crossref_primary_10_1038_s41514_024_00184_y
crossref_primary_10_1186_s12891_025_08456_8
crossref_primary_10_1589_jpts_32_227
crossref_primary_10_23736_S0393_3660_23_04984_7
crossref_primary_10_37586_2686_8636_3_2024_225_239
crossref_primary_10_3390_ijerph19138164
crossref_primary_10_1007_s10067_022_06147_6
crossref_primary_10_1080_14397595_2020_1740411
crossref_primary_10_1016_j_afos_2021_10_001
crossref_primary_10_1093_mr_roaf002
crossref_primary_10_1093_mr_road025
crossref_primary_10_1111_1756_185X_15371
crossref_primary_10_1111_ggi_14924
Cites_doi 10.1093/gerona/52A.3.M129
10.1111/j.1532-5415.2007.01140.x
10.1007/s00776-015-0741-5
10.1093/gerona/56.3.M146
10.1007/s00776-011-0193-5
10.1111/ggi.12397
10.1016/j.jamda.2013.11.025
10.1016/S0899-9007(01)00555-X
10.1093/ageing/afq034
10.1007/s00198-018-4596-4
10.1016/j.archger.2012.06.015
10.1007/s00776-007-1202-6
10.1093/ajcn/50.5.1231
10.1093/jn/127.5.990S
10.1093/gerona/61.10.1059
10.1016/S0899-9007(00)00553-0
10.1007/s00776-011-0160-1
10.1093/ageing/afy169
10.1093/ajcn/64.3.524S
10.1080/14397595.2016.1226471
10.1067/mlc.2001.113504
10.1007/s00774-009-0080-8
10.1152/jappl.2000.89.2.465
10.1007/s00198-016-3823-0
10.1093/ije/dyp276
10.1111/ggi.12037
ContentType Journal Article
Copyright Springer Japan KK, part of Springer Nature 2019
Journal of Bone and Mineral Metabolism is a copyright of Springer, (2019). All Rights Reserved.
Copyright_xml – notice: Springer Japan KK, part of Springer Nature 2019
– notice: Journal of Bone and Mineral Metabolism is a copyright of Springer, (2019). All Rights Reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00774-019-01012-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1435-5604
EndPage 1066
ExternalDocumentID 31222550
10_1007_s00774_019_01012_0
Genre Journal Article
GrantInformation_xml – fundername: Ministry of Education, Culture, Sports, Science and Technology in Japan
  grantid: B26293139
– fundername: Japan Agency for Medical Research and Development
  grantid: 17gk0210007h0003
  funderid: http://dx.doi.org/10.13039/100009619
– fundername: Japan Agency for Medical Research and Development
  grantid: 17gk0210007h0003
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACSNA
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~A9
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QP
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c465t-bfc3e85468f69de2b5c34b64fd342ea1747986e82dcbb77d3154afce3d842b2f3
IEDL.DBID U2A
ISSN 0914-8779
1435-5604
IngestDate Fri Jul 11 16:26:21 EDT 2025
Fri Jul 25 04:58:28 EDT 2025
Mon Jul 21 05:52:48 EDT 2025
Tue Jul 01 04:35:23 EDT 2025
Thu Apr 24 23:05:08 EDT 2025
Fri Feb 21 02:37:38 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Disability
Sarcopenia
Frailty
Co-existence
Locomotive syndrome
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-bfc3e85468f69de2b5c34b64fd342ea1747986e82dcbb77d3154afce3d842b2f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6555-5782
PMID 31222550
PQID 2243884694
PQPubID 1456336
PageCount 9
ParticipantIDs proquest_miscellaneous_2245602846
proquest_journals_2243884694
pubmed_primary_31222550
crossref_primary_10_1007_s00774_019_01012_0
crossref_citationtrail_10_1007_s00774_019_01012_0
springer_journals_10_1007_s00774_019_01012_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-01
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Journal of bone and mineral metabolism
PublicationTitleAbbrev J Bone Miner Metab
PublicationTitleAlternate J Bone Miner Metab
PublicationYear 2019
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References RoubenoffRBaumgartnerRNHarrisTBDallalGEHannanMTEconomosCDStauberPMWilsonPWKielDPApplication of bioelectrical impedance analysis to elderly populationsJ Gerontol A Biol Sci Med Sci199752M129M1361:STN:280:DyaK2szgt1WqsA%3D%3D10.1093/gerona/52A.3.M129
YoshimuraNMurakiSOkaHTanakaSOgataTKawaguchiHAkuneTNakamuraKAssociation between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD studyJ Orthop Sci20152089690510.1007/s00776-015-0741-5
YoshimuraNMurakiSOkaHKawaguchiHNakamuraKAkuneTCohort profile: research on osteoarthritis/osteoporosis against disability (ROAD) studyInt J Epidemiol20103998899510.1093/ije/dyp276
National Institutes of HealthBioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference StatementAm J Clin Nutr199664524S532S10.1093/ajcn/64.3.524S
NakamuraKA ‘super-aged’ society and the ‘locomotive syndrome’J Orthop Sci2008131210.1007/s00776-007-1202-6
ChenLKLiuLKWooJAssantachaiPAuyeungTWSarcopenia in Asia: consensus report of the Asian Working Group for SarcopeniaJ Am Med Dir Assoc2014159510110.1016/j.jamda.2013.11.025
Ministry of Health, Labour, and Welfare (2016) The outline of the results of National Livelihood Survey 2016. http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa16/index.html
GoodpasterBHParkSWHarrisTBKritchevskySBNevittMSchwartzAVSimonsickEMTylavskyFAVisserMNewmanABThe loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition studyJ Gerontol A Biol Sci Med Sci2006611059106410.1093/gerona/61.10.1059
Cruz-JentoftAJBaeyensJPBauerJMBoirieYCederholmTLandiFMartinFCMichelJPRollandYSchneiderSMTopinkováEVandewoudeMZamboniMEuropean Working Group on Sarcopenia in Older PeopleSarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleAge Ageing20103941242310.1093/ageing/afq034
YoshimuraNMurakiSOkaHIidakaTKodamaRKawaguchiHNakamuraKTanakaSAkuneTIs osteoporosis a predictor for future sarcopenia, or vice versa? Four-year observations between the second and third ROAD study surveysOsteoporos Int2017281891991:STN:280:DC%2BC2sjgt1ersQ%3D%3D10.1007/s00198-016-3823-0
KyleUGGentonLKarsegardLSlosmanDOPichardCSingle prediction equation for bioelectrical impedance analysis in adults aged 20–94 yearsNutrition2001172482531:STN:280:DC%2BD3M3itFOjtQ%3D%3D10.1016/S0899-9007(00)00553-0
NemotoMYasbushitaNKimMMatsuoTSeinoSValidity of the bioelectrical impedance method for assessing body composition in non-frail and pre-frail older adultsInt J Body Comps Res2012105562
Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2015TokyoJapanese Orthopaedic Association(in Japanese)
MorleyJEBaumgartnerRNRoubenoffRMayerJNairKSSarcopeniaJ Lab Clin Med20011372312431:STN:280:DC%2BD3M3gvVyrsg%3D%3D10.1067/mlc.2001.113504
JanssenIHeymsfieldSBBaumgartnerRNRossREstimation of skeletal muscle mass by bioelectrical impedance analysisJ Appl Physiol2000894654711:STN:280:DC%2BD3cvjslShsw%3D%3D10.1152/jappl.2000.89.2.465
KyleUGGentonLSlosmanDOPichardCFat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 yearsNutrition2001175345411:STN:280:DC%2BD38%2Fit1Smuw%3D%3D10.1016/S0899-9007(01)00555-X
RosenbergISummary comments: epidemiological and methodological problems in determining nutritional status of older personsAm J Clin Nutr1989501231123310.1093/ajcn/50.5.1231
DelmonicoMJHarrisTBLeeJSVisserMNevittMKritchevskySBTylavskyFANewmanABHealth, Aging and Body Composition StudyAlternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and womenJ Am Geriatr Soc20075576977410.1111/j.1532-5415.2007.01140.x
YoshimuraNMurakiSOkaHMabuchiAEn-yoYYoshidaMSaikaAYoshidaHSuzukiTYamamotoSIshibashiHKawaguchiHNakamuraKAkuneTPrevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability studyJ Bone Miner Metab20092762062810.1007/s00774-009-0080-8
RosenbergIHSarcopenia: origins and clinical relevanceJ Nutr1997127990S991S1:CAS:528:DyaK2sXjtVCnsro%3D10.1093/jn/127.5.990S
AraiHSatakeSEnglish translation of the Kihon checklistGeriatr Gerontol Int20151551851910.1111/ggi.12397
FriedLPTangenCMWalstonJNewmanABHirschCGottdienerJSeemanTTracyRKopWJBurkeGMcBurnieMACardiovascular Health Study Collaborative Research GroupFrailty in older adults: evidence for a phenotypeJ Gerontol A Biol Sci Med Sci200156M146M1561:STN:280:DC%2BD3M7osFejuw%3D%3D10.1093/gerona/56.3.M146
Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2013TokyoJapanese Orthopaedic Association
Cruz-JentoftAJBahatGBauerJBoirieYBruyèreOCederholmTCooperCLandiFRollandYSayerAASchneiderSMSieberCCTopinkovaEVandewoudeMVisserMZamboniMWriting Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)The Extended Group for EWGSOP2Sarcopenia: revised European consensus on definition and diagnosisAge Ageing201948163110.1093/ageing/afy169
TanimotoYWatanabeMSunWSugiuraYTsudaYKimuraMHayashidaIKusabirakiTKonoKAssociation between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in JapanArch Gerontol Geriatr201255e9e1310.1016/j.archger.2012.06.015
Ministry of Health, Labour, and Welfare. Health Japan 21 (the second term). https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf
SeichiAHoshinoYDoiTAkaiMTobimatsuYIwayaTDevelopment of a screening tool for risk of locomotive syndrome in the elderly: the 25-question Geriatric Locomotive Function ScaleJ Orthop Sci20121716317210.1007/s00776-011-0193-5
YoshimuraNMurakiSOkaHIidakaTKodamaRHoriiCKawaguchiHNakamuraKAkuneTTanakaSDo sarcopenia and/or osteoporosis increase the risk of frailty? A four-year observation of the second and third ROAD study surveysOsteoporos Int201829218121901:CAS:528:DC%2BC1cXhtFyjtL3I10.1007/s00198-018-4596-4
TanimotoYWatanabeMSunWTanimotoKShishikuraKSugiuraYKusabirakiTKonoKAssociation of sarcopenia with functional decline in community-dwelling elderly subjects in JapanGeriatr Gerontol Int20131395896310.1111/ggi.12037
YoshimuraNOkaHMurakiSAkuneTHirabayashiNMatsudaSNojiriTHatanakaKIshimotoYNagataKYoshidaMTokimuraFKawaguchiHNakamuraKReference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD studyJ Orthop Sci20111676877710.1007/s00776-011-0160-1
YoshimuraNMurakiSNakamuraKTanakaSEpidemiology of the locomotive syndrome: the research on osteoarthritis/osteoporosis against disability study 2005–2015Mod Rheumatol2017271710.1080/14397595.2016.1226471
I Rosenberg (1012_CR3) 1989; 50
JE Morley (1012_CR5) 2001; 137
N Yoshimura (1012_CR30) 2017; 27
N Yoshimura (1012_CR18) 2018; 29
UG Kyle (1012_CR23) 2001; 17
N Yoshimura (1012_CR16) 2011; 16
UG Kyle (1012_CR24) 2001; 17
Y Tanimoto (1012_CR26) 2012; 55
N Yoshimura (1012_CR15) 2010; 39
IH Rosenberg (1012_CR4) 1997; 127
N Yoshimura (1012_CR19) 2015; 20
M Nemoto (1012_CR28) 2012; 10
Locomotive syndrome (1012_CR13) 2015
I Janssen (1012_CR22) 2000; 89
Y Tanimoto (1012_CR27) 2013; 13
BH Goodpaster (1012_CR6) 2006; 61
R Roubenoff (1012_CR25) 1997; 52
1012_CR31
LP Fried (1012_CR2) 2001; 56
AJ Cruz-Jentoft (1012_CR9) 2019; 48
H Arai (1012_CR29) 2015; 15
K Nakamura (1012_CR11) 2008; 13
N Yoshimura (1012_CR17) 2017; 28
1012_CR1
LK Chen (1012_CR10) 2014; 15
N Yoshimura (1012_CR14) 2009; 27
MJ Delmonico (1012_CR7) 2007; 55
Locomotive syndrome (1012_CR12) 2013
A Seichi (1012_CR20) 2012; 17
National Institutes of Health (1012_CR21) 1996; 64
AJ Cruz-Jentoft (1012_CR8) 2010; 39
References_xml – reference: Cruz-JentoftAJBaeyensJPBauerJMBoirieYCederholmTLandiFMartinFCMichelJPRollandYSchneiderSMTopinkováEVandewoudeMZamboniMEuropean Working Group on Sarcopenia in Older PeopleSarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleAge Ageing20103941242310.1093/ageing/afq034
– reference: TanimotoYWatanabeMSunWSugiuraYTsudaYKimuraMHayashidaIKusabirakiTKonoKAssociation between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in JapanArch Gerontol Geriatr201255e9e1310.1016/j.archger.2012.06.015
– reference: Cruz-JentoftAJBahatGBauerJBoirieYBruyèreOCederholmTCooperCLandiFRollandYSayerAASchneiderSMSieberCCTopinkovaEVandewoudeMVisserMZamboniMWriting Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)The Extended Group for EWGSOP2Sarcopenia: revised European consensus on definition and diagnosisAge Ageing201948163110.1093/ageing/afy169
– reference: YoshimuraNMurakiSOkaHMabuchiAEn-yoYYoshidaMSaikaAYoshidaHSuzukiTYamamotoSIshibashiHKawaguchiHNakamuraKAkuneTPrevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability studyJ Bone Miner Metab20092762062810.1007/s00774-009-0080-8
– reference: DelmonicoMJHarrisTBLeeJSVisserMNevittMKritchevskySBTylavskyFANewmanABHealth, Aging and Body Composition StudyAlternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and womenJ Am Geriatr Soc20075576977410.1111/j.1532-5415.2007.01140.x
– reference: JanssenIHeymsfieldSBBaumgartnerRNRossREstimation of skeletal muscle mass by bioelectrical impedance analysisJ Appl Physiol2000894654711:STN:280:DC%2BD3cvjslShsw%3D%3D10.1152/jappl.2000.89.2.465
– reference: RosenbergIHSarcopenia: origins and clinical relevanceJ Nutr1997127990S991S1:CAS:528:DyaK2sXjtVCnsro%3D10.1093/jn/127.5.990S
– reference: YoshimuraNMurakiSOkaHIidakaTKodamaRKawaguchiHNakamuraKTanakaSAkuneTIs osteoporosis a predictor for future sarcopenia, or vice versa? Four-year observations between the second and third ROAD study surveysOsteoporos Int2017281891991:STN:280:DC%2BC2sjgt1ersQ%3D%3D10.1007/s00198-016-3823-0
– reference: NemotoMYasbushitaNKimMMatsuoTSeinoSValidity of the bioelectrical impedance method for assessing body composition in non-frail and pre-frail older adultsInt J Body Comps Res2012105562
– reference: RoubenoffRBaumgartnerRNHarrisTBDallalGEHannanMTEconomosCDStauberPMWilsonPWKielDPApplication of bioelectrical impedance analysis to elderly populationsJ Gerontol A Biol Sci Med Sci199752M129M1361:STN:280:DyaK2szgt1WqsA%3D%3D10.1093/gerona/52A.3.M129
– reference: GoodpasterBHParkSWHarrisTBKritchevskySBNevittMSchwartzAVSimonsickEMTylavskyFAVisserMNewmanABThe loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition studyJ Gerontol A Biol Sci Med Sci2006611059106410.1093/gerona/61.10.1059
– reference: RosenbergISummary comments: epidemiological and methodological problems in determining nutritional status of older personsAm J Clin Nutr1989501231123310.1093/ajcn/50.5.1231
– reference: YoshimuraNMurakiSOkaHKawaguchiHNakamuraKAkuneTCohort profile: research on osteoarthritis/osteoporosis against disability (ROAD) studyInt J Epidemiol20103998899510.1093/ije/dyp276
– reference: YoshimuraNOkaHMurakiSAkuneTHirabayashiNMatsudaSNojiriTHatanakaKIshimotoYNagataKYoshidaMTokimuraFKawaguchiHNakamuraKReference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD studyJ Orthop Sci20111676877710.1007/s00776-011-0160-1
– reference: KyleUGGentonLKarsegardLSlosmanDOPichardCSingle prediction equation for bioelectrical impedance analysis in adults aged 20–94 yearsNutrition2001172482531:STN:280:DC%2BD3M3itFOjtQ%3D%3D10.1016/S0899-9007(00)00553-0
– reference: YoshimuraNMurakiSNakamuraKTanakaSEpidemiology of the locomotive syndrome: the research on osteoarthritis/osteoporosis against disability study 2005–2015Mod Rheumatol2017271710.1080/14397595.2016.1226471
– reference: Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2015TokyoJapanese Orthopaedic Association(in Japanese)
– reference: YoshimuraNMurakiSOkaHTanakaSOgataTKawaguchiHAkuneTNakamuraKAssociation between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD studyJ Orthop Sci20152089690510.1007/s00776-015-0741-5
– reference: National Institutes of HealthBioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference StatementAm J Clin Nutr199664524S532S10.1093/ajcn/64.3.524S
– reference: AraiHSatakeSEnglish translation of the Kihon checklistGeriatr Gerontol Int20151551851910.1111/ggi.12397
– reference: Ministry of Health, Labour, and Welfare (2016) The outline of the results of National Livelihood Survey 2016. http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa16/index.html
– reference: SeichiAHoshinoYDoiTAkaiMTobimatsuYIwayaTDevelopment of a screening tool for risk of locomotive syndrome in the elderly: the 25-question Geriatric Locomotive Function ScaleJ Orthop Sci20121716317210.1007/s00776-011-0193-5
– reference: TanimotoYWatanabeMSunWTanimotoKShishikuraKSugiuraYKusabirakiTKonoKAssociation of sarcopenia with functional decline in community-dwelling elderly subjects in JapanGeriatr Gerontol Int20131395896310.1111/ggi.12037
– reference: MorleyJEBaumgartnerRNRoubenoffRMayerJNairKSSarcopeniaJ Lab Clin Med20011372312431:STN:280:DC%2BD3M3gvVyrsg%3D%3D10.1067/mlc.2001.113504
– reference: Ministry of Health, Labour, and Welfare. Health Japan 21 (the second term). https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf)
– reference: YoshimuraNMurakiSOkaHIidakaTKodamaRHoriiCKawaguchiHNakamuraKAkuneTTanakaSDo sarcopenia and/or osteoporosis increase the risk of frailty? A four-year observation of the second and third ROAD study surveysOsteoporos Int201829218121901:CAS:528:DC%2BC1cXhtFyjtL3I10.1007/s00198-018-4596-4
– reference: ChenLKLiuLKWooJAssantachaiPAuyeungTWSarcopenia in Asia: consensus report of the Asian Working Group for SarcopeniaJ Am Med Dir Assoc2014159510110.1016/j.jamda.2013.11.025
– reference: KyleUGGentonLSlosmanDOPichardCFat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 yearsNutrition2001175345411:STN:280:DC%2BD38%2Fit1Smuw%3D%3D10.1016/S0899-9007(01)00555-X
– reference: Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2013TokyoJapanese Orthopaedic Association
– reference: FriedLPTangenCMWalstonJNewmanABHirschCGottdienerJSeemanTTracyRKopWJBurkeGMcBurnieMACardiovascular Health Study Collaborative Research GroupFrailty in older adults: evidence for a phenotypeJ Gerontol A Biol Sci Med Sci200156M146M1561:STN:280:DC%2BD3M7osFejuw%3D%3D10.1093/gerona/56.3.M146
– reference: NakamuraKA ‘super-aged’ society and the ‘locomotive syndrome’J Orthop Sci2008131210.1007/s00776-007-1202-6
– volume: 52
  start-page: M129
  year: 1997
  ident: 1012_CR25
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/52A.3.M129
– volume: 55
  start-page: 769
  year: 2007
  ident: 1012_CR7
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2007.01140.x
– volume: 20
  start-page: 896
  year: 2015
  ident: 1012_CR19
  publication-title: J Orthop Sci
  doi: 10.1007/s00776-015-0741-5
– volume: 56
  start-page: M146
  year: 2001
  ident: 1012_CR2
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/56.3.M146
– volume: 17
  start-page: 163
  year: 2012
  ident: 1012_CR20
  publication-title: J Orthop Sci
  doi: 10.1007/s00776-011-0193-5
– volume: 15
  start-page: 518
  year: 2015
  ident: 1012_CR29
  publication-title: Geriatr Gerontol Int
  doi: 10.1111/ggi.12397
– volume: 15
  start-page: 95
  year: 2014
  ident: 1012_CR10
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2013.11.025
– volume: 17
  start-page: 534
  year: 2001
  ident: 1012_CR23
  publication-title: Nutrition
  doi: 10.1016/S0899-9007(01)00555-X
– volume: 39
  start-page: 412
  year: 2010
  ident: 1012_CR8
  publication-title: Age Ageing
  doi: 10.1093/ageing/afq034
– volume: 29
  start-page: 2181
  year: 2018
  ident: 1012_CR18
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-018-4596-4
– volume: 55
  start-page: e9
  year: 2012
  ident: 1012_CR26
  publication-title: Arch Gerontol Geriatr
  doi: 10.1016/j.archger.2012.06.015
– volume: 13
  start-page: 1
  year: 2008
  ident: 1012_CR11
  publication-title: J Orthop Sci
  doi: 10.1007/s00776-007-1202-6
– volume-title: Locomotive syndrome pamphlet
  year: 2015
  ident: 1012_CR13
– volume: 10
  start-page: 55
  year: 2012
  ident: 1012_CR28
  publication-title: Int J Body Comps Res
– volume: 50
  start-page: 1231
  year: 1989
  ident: 1012_CR3
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/50.5.1231
– volume: 127
  start-page: 990S
  year: 1997
  ident: 1012_CR4
  publication-title: J Nutr
  doi: 10.1093/jn/127.5.990S
– volume: 61
  start-page: 1059
  year: 2006
  ident: 1012_CR6
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/61.10.1059
– volume: 17
  start-page: 248
  year: 2001
  ident: 1012_CR24
  publication-title: Nutrition
  doi: 10.1016/S0899-9007(00)00553-0
– ident: 1012_CR1
– volume: 16
  start-page: 768
  year: 2011
  ident: 1012_CR16
  publication-title: J Orthop Sci
  doi: 10.1007/s00776-011-0160-1
– volume-title: Locomotive syndrome pamphlet
  year: 2013
  ident: 1012_CR12
– volume: 48
  start-page: 16
  year: 2019
  ident: 1012_CR9
  publication-title: Age Ageing
  doi: 10.1093/ageing/afy169
– volume: 64
  start-page: 524S
  year: 1996
  ident: 1012_CR21
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/64.3.524S
– volume: 27
  start-page: 1
  year: 2017
  ident: 1012_CR30
  publication-title: Mod Rheumatol
  doi: 10.1080/14397595.2016.1226471
– volume: 137
  start-page: 231
  year: 2001
  ident: 1012_CR5
  publication-title: J Lab Clin Med
  doi: 10.1067/mlc.2001.113504
– volume: 27
  start-page: 620
  year: 2009
  ident: 1012_CR14
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-009-0080-8
– volume: 89
  start-page: 465
  year: 2000
  ident: 1012_CR22
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.2000.89.2.465
– volume: 28
  start-page: 189
  year: 2017
  ident: 1012_CR17
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-016-3823-0
– volume: 39
  start-page: 988
  year: 2010
  ident: 1012_CR15
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyp276
– volume: 13
  start-page: 958
  year: 2013
  ident: 1012_CR27
  publication-title: Geriatr Gerontol Int
  doi: 10.1111/ggi.12037
– ident: 1012_CR31
SSID ssj0017571
Score 2.5045578
Snippet This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1058
SubjectTerms Aged
Arthritis
Cohort Studies
Disability Evaluation
Female
Frailty
Frailty - complications
Frailty - epidemiology
Humans
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Original Article
Orthopedics
Osteoarthritis
Osteoarthritis - complications
Osteoarthritis - epidemiology
Osteoporosis
Osteoporosis - complications
Osteoporosis - epidemiology
Prevalence
Sarcopenia
Sarcopenia - complications
Sarcopenia - epidemiology
Surveys and Questionnaires
Syndrome
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3faxNBEF40QvFFrFaNxrKCDxWzNLnb-7G-SGgtRdBCMZC3Y3_Wg3JXc5dC_iP_TGc2exdKMA_3EO5uszCz932zO_MNIR9tBNNLkpxh0SfjAMlMacXZRCFcOYmbWJht8TO9nPPvi2QRNtyakFbZfRP9h9rUGvfITwFq4hzAUvCvd38Ydo3C09XQQuMxeYLSZejV2aIPuAAZfcAFkMhh1WciFM340jnUscH8C8wWmmB6wkNg2mGbOyelHoAunpNngTnS2cbUh-SRrV6Qgx_hbPwl-YtqTNLXEFFZGaprhjKXnhPT2lFALZ95d29pJ1Mwpg34OTbQKuXYv-SWsrxt118o8EK4yqWhzWp5b9c4QpelR-uKXsHANbjdby-KdOp_ApWvm7KhsxtZAuuk50G_t13Tk-ur2fkn6sVsj8j84tuvs0sW-jAwzdOkZcrp2OYJT3OXCmMjleiYq5Q7E3MwNcQ0mchTm0dGK5VlJgZaJp22scl5pCIXvyKDqq7sG0KdEDI3mRZpIiGynCrwlMhACCYMEFOhhmTaGaHQQaQce2XcFr28sjdcAYYrvOGKyZB87t-520h07H161Nm2CMu1KbbONSQf-tuw0PD0RFa2XvlngB0CmqdD8nrjE_3fxVMMmxMYfNw5yXbw_8_l7f65vCNPI3RQX_k4IoN2ubLvgQK16tj7-T92QQKP
  priority: 102
  providerName: ProQuest
Title Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study
URI https://link.springer.com/article/10.1007/s00774-019-01012-0
https://www.ncbi.nlm.nih.gov/pubmed/31222550
https://www.proquest.com/docview/2243884694
https://www.proquest.com/docview/2245602846
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB_6AeKL2NaP03qs4EPFC94lu0nWt7S9WixtpXhwPoX91EBJ5JIr3H_kn-nsXpIitUIfQgjZTBZmNvObzMxvAd6ZEKfHWBq4ps-AoksOpJI0GEvnrqxwP7FctcVFfDqjX-Zs3jaF1V21e5eS9F_qvtnNMc-4iglX3zN2BQWbsM0wdneFXLMw63MHCfNhFjpCims94W2rzL9l_O2O7mDMO_lR73ZOnsKTFi-SbK3gHdgw5S48Om8z4nvw23EwCd85RESpiaoCR27pkTCpLEFf5evtbgzpyAlGpEbrdttmFWLkH7ILUVw3q08E0SAexUKTerm4MSsnoavNI1VJLlFwhcb201MhffSXCOCruqhJ9kMUiDXJccva26zIwdVldvyeeArbZzA7mX47Og3a3RcCRWPWBNKqyKSMxqmNuTahZCqiMqZWRxQVjJFMwtPYpKFWUiaJjhCMCatMpFMaytBGz2GrrErzEojlXKQ6UTxmAuPJiUT7CDUGXlwjHOVyAJNOCblqqcndDhnXeU-q7BWXo-Jyr7h8PIAP_TO_1sQc_x293-k2bxdpnSN6iVLEX5wO4G1_G5eXy5mI0lRLPwYxIfrweAAv1jbRvy6auGCZofBRZyS3wu-fy6uHDX8Nj0NnsL7_cR-2msXSvEEg1MghbCbzZAjb2efvZ1M8H04vvl4N_Wr4AzzTA2E
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RQEB5qBe2LeO9q1SMoKG7o7snJTRBZXMvW3kBa2Ld4bmkDJambbGX_UZ_6G505m6RIsW99yENIMjnJTM58kzPzDcA7y3F4QRB7VPTpCXTJntJKeANF7iqT9BOLsi32w8mR-DENpitw2dbCUFplOye6idqUmv6Rb6Kr8WN0lon4evbbo65RtLrattBYmsWOXfzBkK36sj1G_b7nfOv74beJ13QV8LQIg9pTmfZtHIgwzsLEWK4C7QsVisz4AgeOCD1K4tDG3Gilosj4CDJkpq1vYsEVz3yUewfu4pMMKNiLpl2Ah57YBXjoggXOMlHSFOm4Uj3izaF8D8pOGlA6xL-O8Bq6vbYy6xze1kN40CBVNlqa1iNYscVjuLfXrMU_gQtif5KuZonJwjBdekSr6TA4KzOGXtJl-p1b1tIi9FmFL5AaduWy7y7KZjI_rRefGeJQ3PKZYdV8dm4XJKHNCmRlwQ5QcIlmfuJImDbdLoYOZZVXbHQsc0S5bNzwBdcL9uHnwWj8kTny3KdwdCsaegarRVnYdWBZksjYRDoJA4mR7FChZXKDIV9iEAgnqgfDVgmpbkjRqTfHadrROTvFpai41CkuHfTgU3fN2ZIS5MazN1rdps30UKVXxtyDt91h_LBptUYWtpy7cxCNInoIe_B8aRPd7fwhhekBCu-3RnIl_P9jeXHzWN7A_cnh3m66u72_8xLWOBmrq7rcgNV6NrevEH7V6rWzeQa_bvsj-wszkkB8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxNREB5qCsUX8W606hEUFLMk2T17E0SiaWitpqVY6Nv2XNuFsluzSSX_yN_gr3PmZHeLFPvWhzyE7E5OMnPOfLMz8w3Aa-Pj8sIw8ajp0-Pokj2pJPcGktyVFfQQi6otptH2If96FB6twZ-mF4bKKpsz0R3UulT0jLyPriZI0FmmvG_rsoj98eTT-U-PJkhRprUZp7EykV2z_IXhW_VxZ4y6fuP7k60fX7a9esKAp3gUzj1pVWCSkEeJjVJtfBmqgMuIWx1w_BGI1uM0iUziayVlHOsAAYewygQ64b70bYByb8F6TFFRB9Y_b033D9ocRhy6cA8dMsczJ07rlh3XuEcsOlT9QbVKAyqO-NctXsG6V_K0zv1N7sKdGrey0crQ7sGaKe7Dxvc6M_8AfhMXlHAdTEwUmqnSI5JNh8hZaRn6TFf3d2FYQ5LQYxX-hTS-Kxc9d5OdifxsvvzAEJXiK59pVi1mF2ZJEpoaQVYWbA8Fl2j0p46Sqe_eYiBRVnnFRiciR8zLxjV78HzJ3h7sjcbvmKPSfQiHN6KjR9ApysI8AWbTVCQ6VmkUCoxrhxLt1NcYAKYaYXEquzBslJCpmiKdJnWcZS25s1NchorLnOKyQRfet_ecrwhCrr16s9FtVh8WVXZp2l141X6M25xyN6Iw5cJdg9gUsUTUhccrm2i_LhhS0B6i8F5jJJfC_7-Wp9ev5SVs4AbLvu1Md5_BbZ9s1bVgbkJnPluY54jF5vJFbfQMjm96n_0FpHpGFw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+co-existence+of+locomotive+syndrome%2C+sarcopenia%2C+and+frailty%3A+the+third+survey+of+Research+on+Osteoarthritis%2FOsteoporosis+Against+Disability+%28ROAD%29+study&rft.jtitle=Journal+of+bone+and+mineral+metabolism&rft.au=Yoshimura%2C+Noriko&rft.au=Muraki%2C+Shigeyuki&rft.au=Iidaka%2C+Toshiko&rft.au=Oka%2C+Hiroyuki&rft.date=2019-11-01&rft.pub=Springer+Japan&rft.issn=0914-8779&rft.eissn=1435-5604&rft.volume=37&rft.issue=6&rft.spage=1058&rft.epage=1066&rft_id=info:doi/10.1007%2Fs00774-019-01012-0&rft.externalDocID=10_1007_s00774_019_01012_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-8779&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-8779&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-8779&client=summon